Recent Finacing
Recent Raise
Infinity Bio operates a MIPSA platform for unbiased antibody-reactome profiling (HuSIGHT, VirSIGHT), processing thousands of samples weekly for academic, government, and biopharma customers from 9,000 sq ft Baltimore lab.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
